secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001161697-24-000225
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical Q1 revenue up 11% to $8.2M; gross margin expands 620bps to 62.3%
-----------------------------------------------------------------------------

- Net revenues of $8.2M, +10.9% YoY; Core business grew 13.6%, driven by 63% International increase.
- Gross margin 62.3% vs 56.1% YoY, aided by outsourced manufacturing and US site consolidation.
- Net loss narrowed to $1.9M ($0.04/share) from $2.4M; Adj EBITDA loss improved to $0.9M.
- Reaffirmed FY2024 revenue guidance of $31.2-32.2M (10-13% growth); gross margin 59-61% expected.
- Added a novel oncology therapy collaboration, bringing total to 16, with 3 YTD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169724000225/0001161697-24-000225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169724000225/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-24-000225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer